A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream

Summary

This is a phase 2, randomised, open-label, parallel-group, multicentre trial in which MC2-01 cream and calcipotriene \[CAL\]/betamethasone \[BDP\] ointment (comparator) is investigated in subjects with clinically diagnosed extensive psoriasis vulgaris.

Timeline

Start

2018-02-08

Primary completion

2018-08-04

Completion

2018-08-04

Drugs

Indications